Abemaciclib For Solid Tumors
Contact
Description
The purpose of this study is to determine the highest safe dose of abemaciclib in patients with relapsed or treatment refractory solid tumors given in combination with the chemotherapy drugs, irinotecan and temozolomide (Part A) or in combination with just temozolomide (Part B).
Eligibility and criteria
IRB Number:
20-017832
Eligible age range:
Clinical trial phase:
Phase I
Official title:

We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.